channels, and human TRP1 (hTRP1) expression are essential in human pulmonary arterial smooth muscle cell (PASMC) proliferation. Chelation of extracellular Ca 2ϩ and depletion of intracellularly stored Ca 2ϩ inhibited PASMC growth in media containing serum and growth factors. Resting [Ca 2ϩ ] cyt as well as the increases in [Ca 2ϩ ] cyt due to Ca 2ϩ release and CCE were all significantly greater in proliferating PASMC than in growth-arrested cells. Consistently, whole cell inward currents activated by depletion of intracellular Ca 2ϩ stores and the mRNA level of hTRP1 were much greater in proliferating PASMC than in growth-arrested cells. These results suggest that elevated [Ca 2ϩ ] cyt and intracellularly stored [Ca 2ϩ ] play an important role in pulmonary vascular smooth muscle cell growth. CCE, potentially via hTRP1-encoded Ca 2ϩ -permeable channels, may be an important mechanism required to maintain the elevated [Ca 2ϩ ] cyt and stored [Ca 2ϩ ] in human PASMC during proliferation. transient receptor potential gene; pulmonary hypertension; pulmonary artery smooth muscle cells PULMONARY ARTERIAL PRESSURE is the function of cardiac output and pulmonary vascular resistance. Pulmonary vasoconstriction and vascular medial hypertrophy (due to smooth muscle cell proliferation) greatly contribute to the increased pulmonary vascular resistance in patients with primary pulmonary hypertension (PPH), a fatal disease with an unknown cause (31, 38 (30) . A common hypothesis is that vasoconstriction and cell proliferation, two linked phenomena in the etiology of PPH (31) , use overlapping signaling processes that result in parallel intracellular events (35, 38) .
Intracellular Ca 2ϩ is a critical signal transduction element in regulating muscle contraction (34), gene expression (8, 19) , and cell proliferation (6, 16, 28) . Because Ca 2ϩ diffuses rapidly between the cytosol and nucleus (1) , an increase in [Ca 2ϩ ] cyt activates Ca 2ϩ -dependent events occurring in both the cytosol and nucleus. A variety of mitogenic agents stimulate cell growth by increasing [Ca 2ϩ ] cyt (6, 16, 23, 28, 32) . The mitogen-mediated changes in [Ca 2ϩ ] cyt usually consist of initial Ca 2ϩ release from the SR followed by sustained Ca 2ϩ entry through sarcolemmal Ca 2ϩ channels. Depletion of Ca 2ϩ from the SR due to the agonistinduced Ca 2ϩ release triggers Ca 2ϩ influx through store-operated Ca 2ϩ channels (SOCs) in the plasma membrane, namely capacitative Ca 2ϩ entry (CCE) (29) . Therefore, CCE is a mechanism that links [Ca 2ϩ ] SR to membrane Ca 2ϩ permeability (4, 27) and serves as an important pathway to refill intracellular Ca 2ϩ stores and maintain sustained Ca 2ϩ influx (27) . A novel gene family, transient receptor potential (TRP) genes, which are essential for agonist-activated CCE, have recently been cloned in mammals and humans (hTRP) (4, 39, 44, 45) . Expression of TRP genes has been demonstrated to form the Ca 2ϩ -permeable cation channels that are activated by Ca 2ϩ store depletion. This suggests that the TRP-encoded proteins may be the putative channels responsible for CCE (4, 5, 37, 40, 44, 45) .
In vascular smooth muscle cells, sustained Ca 2ϩ influx and maintaining sufficient Ca 2ϩ in the SR are both required for cell growth (15, 33 ] SR that are necessary for human pulmonary arterial smooth muscle cell (PASMC) proliferation.
MATERIALS AND METHODS
Cell preparation and culture. Patients undergoing lobectomy for bronchogenic carcinoma and lung/heart transplantation for cardiopulmonary diseases, who had no evidence of pulmonary hypertension, were the source of control lung tissues for preparing primary cultured PASMC. In some cases, patients undergoing lung transplantation with PPH or secondary pulmonary hypertension (SPH; e.g., patients with congenital heart disease and pulmonary thromboembolic disease) were the source of diseased lung tissues. Lung tissues were removed from patients in the operating room and immediately placed in cold (4°C) saline and taken to the laboratory for dissection (41) .
Small muscular intrapulmonary arteries were isolated and incubated for 20 min in Hank's balanced salt solution containing 2 mg/ml collagenase (Worthington). After the incubation, the adventitia was carefully stripped off, and the endothelium was removed. Remaining smooth muscle was digested with 2.0 mg/ml collagenase (Worthington), 0.5 mg/ml elastase, and 1 mg/ml bovine albumin (Sigma) at 37°C. Single PASMC were resuspended, plated onto 25-mm cover slips (for fluorescence microscopy and electrophysiological experiments) or 10-cm Petri dishes (for molecular biological experiments), and incubated in a humidified atmosphere of 5% CO 2 in air at 37°C (41) .
The cells were cultured in smooth muscle growth medium (Clonetics), which consisted of smooth muscle basal medium, 5% fetal bovine serum, 5 g/ml insulin, 2 ng/ml human fibroblast growth factor, and 0.5 ng/ml human endothelial growth factor (Clonetics), for 5-7 days before each experiment. In some experiments, normal human PASMC (Clonetics) were used at passages 4-6. The cells were stained with the membrane-permeable nucleic acid stain 4Ј,6Ј-diamidino-2-phenylindole (5 M, Molecular Probes). All the 4Ј,6Ј-diamidino-2-phenylindole-stained cells in the cultures crossreacted with the smooth muscle cell ␣-actin antibody, indicating that the cultures consisted only of smooth muscle cells. There were no significant morphological differences between the cells cultured in media with or without serum and growth factors. Cell counts were determined using a hemocytometer. The viable cell number normalized by size of the Petri dishes (in cells/cm 2 ) was used to compare cell growth rate. Measurement of [Ca 2ϩ ] cyt . The cells were loaded in culture medium containing the acetoxymethyl ester form of fura 2 (fura 2-AM; 3 M, Molecular Probes) for 30 min at room temperature under an atmosphere of 5% CO 2 in air (10). The fura 2-loaded cells were then superfused with standard bath solution for 30 min at 32-34°C to wash away extracellular dye and permit intracellular esterases to cleave cytosolic fura 2-AM into active fura 2. Fura 2 fluorescence (510-nm emission; 380-and 360-nm excitation) from the cells and background fluorescence were imaged using a GEN III chargecoupled device camera (Stanford Photonics) coupled to a Carl Zeiss microscope. Fluorescent images were obtained using a microchannel plate image intensifier (Amperex XX1381) coupled by fiber optics to the charged-coupled device camera. Image acquisition and analysis were performed with a MetaMorph imaging system (Universal Imaging). Video frames containing images of fura 2 fluorescence from cells, as well as the corresponding background images (fluorescence from fields devoid of cells), were digitized at a resolution of 512 horizontal ϫ 480 vertical pixels and an 8-bit grey scale using a Matrix LC imaging board operating in an IBM-compatible PC. To improve the signal-to-noise ratio, four to eight consecutive video frames were usually averaged at a video frame rate of 30 frames/s. Images were acquired at a rate of one averaged image every 3 s when [Ca 2ϩ ] cyt was changing and every 60 s when [Ca 2ϩ ] cyt was stable. [Ca 2ϩ ] cyt was calculated from fura 2 fluorescent emission excited at 380 and 360 nm using the ratio method (11) . In most experiments, multiple (6-10) cells were imaged in single field, and one arbitrarily chosen peripheral cytosolic area (4-6 ϫ 4-6 pixels) from each cell was spatially averaged. currents (I CRAC ) were recorded with an Axopatch-1D amplifier and a DigiData 1200 interface (Axonpatch) using patchclamp techniques (12) . Patch pipettes (2-4 M⍀) were fabricated on a Sutter electrode puller using borosilicate glass tubes and fire polished on a microforge (Narishige). For whole cell current recordings, voltage stimuli lasting 300 ms were delivered from a holding potential of 0 mV (to inactivate voltage-gated Ca 2ϩ and Na ϩ channels) using voltage steps from ϩ80 mV to Ϫ80 mV. Traces recorded before the activation of SOCs were used as a template to subtract leak currents. All experiments were performed at room temperature (22-24°C) . In both whole cell and single-channel configurations, SOCs were activated by passive depletion of the SR using 10 M cyclopiazonic acid (CPA; Sigma) dissolved in the Ca 2ϩ -free solution. Solution and reagents. For [Ca 2ϩ ] cyt measurement experiments, the cells were superfused (2-3 ml/min) with physiological salt solution (PSS). The PSS contained (in mM) 141 NaCl, 4.7 KCl, 1.8 CaCl 2 , 1.2 MgCl 2 , 10 HEPES, and 10 glucose (pH 7.4 with 5 M NaOH). The bath solution for recording whole cell I CRAC contained (in mM) 120 sodium methane sulfonate, 20 calcium aspartate, 0.5 3,4-diaminopyridine, 10 glucose, and 10 HEPES (pH 7.4 with methane sulfonic acid). The pipette (intracellular) solution contained (in mM) 138 cesium aspartate, 1.15 EGTA, 1 Ca(OH) 2 , 2 Na 2 ATP, and 10 HEPES (pH 7.2). These ionic conditions eliminated the currents through K ϩ or Cl Ϫ channels. In Ca 2ϩ -free PSS, CaCl 2 was replaced by equimolar MgCl 2 , and 1 mM EGTA was added to chelate residual Ca CPA and thapsigargin (Sigma) were dissolved into DMSO to make stock solutions of 30 and 10 mM, respectively. Aliquots of the stock solutions were then diluted 1:3,000-10,000 into the bath solution or culture medium to make final concentrations of 10 M CPA (pH 7.4) and 1 M thapsigargin. Nifedipine (Sigma) and Ni 2ϩ (Sigma) were directly dissolved in the bath solutions on the day of use. The pH values of all solutions were checked after addition of the drugs and readjusted to 7.4. In [Ca 2ϩ ] cyt and I CRAC measurement experiments, the same amount of DMSO used for dissolving CPA was added to control solutions (0.03%). Vehicle (DMSO) alone had negligible effects on [Ca 2ϩ ] cyt and I CRAC in PASMC.
RT-PCR assay. Total RNA (2-3 g) prepared from the cells by the acid guanidinium thiocyanate-phenol-chloroform extraction method, was reverse-transcribed using the First-Strand cDNA synthesis kit (Pharmacia Biotech). The sense/antisense primers were designed from coding regions of hTRP1 [5Ј-CAAGATTT-TGGAAAATTTCTTG-3Ј (nt. The cDNA samples were amplified in a DNA thermal cycler (Perkin-Elmer) under the following conditions: the mixture was annealed at 50-61°C (for 1 min), extended at 72°C (for 2 min), and denatured at 94°C (for 1 min) for 25 cycles. This was followed by a final extension at 72°C (for 10 min) to ensure complete product extension. The PCR products were electrophoresed through a 1% agarose gel, and amplified cDNA bands were visualized by ethidium bromide staining. The PCR product was sequenced, and the result indicated that the sequence of our PCR product using the sense and antisense primers designed for hTRP1 matched exactly with the hTRP1 sequence (U31110) in GenBank. To quantify the PCR products, an invariant mRNA of human ␤-actin was used as an internal control. The OD value for each band on the gel was measured by a Gel Documentation System (UVP). The OD values in the channel signals were normalized to the OD values in the ␤-actin signals; the ratios are expressed as arbitrary units for quantitative comparison.
Statistical analysis. The composite data are expressed as means Ϯ SE. Statistical analyses were performed using unpaired Student's t-test or ANOVA and post hoc tests (Student Newman-Keuls) where appropriate. Differences were considered to be significant when P Ͻ 0.05. ] cyt can activate cytoplasmic mitogen-activated protein kinase (6) (which is part of the phosphorylation cascade that leads to activation of DNA synthesis-promoting factor), rapidly increase nuclear [Ca 2ϩ ] (1), and promote cell proliferation (22) . The addition of 2 mM EDTA, a Ca 2ϩ chelator, to the culture medium (which contains 1.6 mM Ca 2ϩ ) decreases the free [Ca 2ϩ ] to 59 M (9) and significantly inhibited human PASMC growth in media containing 5% fetal bovine serum and growth factors (Fig. 1) . Depletion of intracellular Ca 2ϩ stores (mainly the SR) with 1 M thapsigargin further inhibited proliferation of human PASMC cultured in media containing 2 mM EDTA (Fig. 1 ). These results demonstrate that a sustained Ca 2ϩ influx through sarcolemmal Ca 2ϩ channels and sufficient [Ca 2ϩ ] maintained within the SR (33) are both required for PASMC growth.
RESULTS

Requirement of extracellular
Increased resting [Ca 2ϩ ] cyt and CCE in proliferating PASMC. Withdrawal of serum and growth factors from culture media abolished cell growth (Fig. 1) . This indicates that the cells cultured in smooth muscle basal medium (without serum and growth factors) are growth-arrested cells, whereas the cells cultured in smooth muscle growth medium (smooth muscle basal medium supplemented with 5% fetal bovine serum and growth factors) are proliferating cells.
In ] cyt , which was obviously due to CCE ( Fig. 2A) The peak increase in [Ca 2ϩ ] cyt due to CCE was significantly enhanced in proliferating human PASMC (1,712 Ϯ 63 nM, n ϭ 98) compared with growth-arrested cells (369 Ϯ 22 nM, n ϭ 92, P Ͻ 0.001) (Fig. 2) . Furthermore, the resting [Ca 2ϩ ] cyt (171 Ϯ 6 vs. 88 Ϯ 4 nM, P Ͻ 0.01) and the CPA-mediated Ca 2ϩ transients (due to Ca 2ϩ release from the SR) (614 Ϯ 31 vs. 301 Ϯ 29 nM, P Ͻ 0.01) were also significantly higher in proliferating PASMC (n ϭ 98) than in growth-arrested cells (n ϭ 92).
Inhibitory effects of Ni 2ϩ on CCE and PASMC growth. Blockade of L-type VDCC with nifedipine (1 M) abolished the 40 mM K ϩ -induced increase in Fig. 1 . Chelation of extracellular Ca 2ϩ and depletion of intracellularly stored Ca 2ϩ in the sarcoplasmic reticum (SR) inhibit human pulmonary arterial smooth muscle cell (PASMC) growth. Cell numbers were determined before (basal) and after 2-day incubation of the cells in smooth muscle basal medium [SMBM, without serum and growth factors (GF)] and smooth muscle growth medium (SMGM, which is composed of SMBM, 5% fetal bovine serum, and growth factors) containing EDTA (2 mM), thapsigargin (TG, 1 M) or EDTA ϩ TG. Data are means Ϯ SE (n ϭ 6). ***P Ͻ 0.001 vs. SMGM.
[Ca 2ϩ ] cyt but had little effect on the CCE-mediated increase in [Ca 2ϩ ] cyt (Fig. 3A, top) . CCE is largely determined by the conductance of SOCs when the transmembrane Ca 2ϩ electrochemical gradient is constant. Ni 2ϩ has been demonstrated to block SOCs (46). Indeed, Ni 2ϩ (0.5 mM) or SKF-96365 (10 M) (7) significantly attenuated CCE in proliferating PASMC in the presence of nifedipine (Fig. 3A) . Accordingly, treatment of the cells with 0.5 mM Ni 2ϩ for 2 days significantly diminished human PASMC growth in media containing serum and growth factors (Fig. 3B) .
Increased SOC activity in proliferating PASMC. The flux of Ca 2ϩ ions through SOCs has been defined electrophysiologically as I CRAC (14, 17, 18, 20, 27) . Whole cell I CRAC were recorded in cells superfused with solutions containing 120 mM Na ϩ and 20 mM Ca 2ϩ and dialyzed with solutions containing 138 mM Cs ϩ and ϳ100 nM free Ca 2ϩ . Holding potential was set at 0 mV to inactivate voltage-gated Na ϩ and Ca 2ϩ channels. Whole cell I CRAC were elicited by 300-ms voltage steps from Ϫ80 to ϩ80 mV before and after application of 10 M CPA (Fig. 4A) . Subtracting the currents recorded under control conditions from the currents recorded after 10-15 min application of CPA revealed I CRAC that were activated by CPA-induced depletion of the SR Ca 2ϩ (Fig. 4A, right) . The inward current was apparently carried by Ca 2ϩ (and Na ϩ ), and the outward current was carried by Cs ϩ (Cs permeability ϭ Na permeability for SOCs) (2, 17, 18) .
Consistent with the results on CCE, whole cell I CRAC were much greater in proliferating cells than in growth-arrested cells (Fig. 4) . The averaged amplitudes of I CRAC , elicited by Ϫ80 mV, were Ϫ252 Ϯ 69 pA in proliferating cells and Ϫ33 Ϯ 12 pA in growtharrested cells (Fig. 4B, right) . Extracellular application of Mg 2ϩ (2 mM), which has been demonstrated to inhibit CCE in vascular smooth muscle cells (2, 10), significantly reduced whole cell I CRAC in both growtharrested (by 16 Ϯ 2% at ϩ80 mV, P Ͻ 0.01) and proliferating (by 22 Ϯ 2%, P Ͻ 0.01) PASMC.
Single-channel I CRAC were recorded in cell-attached patches from proliferating PASMC using the ionic conditions under which inward Ca 2ϩ (or Na ϩ ) currents could be displayed at negative holding potentials for the patches. While the cell was held at Ϫ45 mV, application of 10 M CPA (for 4-8 min) gradually induced a small amplitude inward current that was apparently carried by Ca 2ϩ (or Na ϩ ) through SOCs (Fig. 5A) . The slope conductance of this current, calculated from the current-voltage relationship curve, is 5.34 pS (Fig. 5B) .
Enhanced hTRP1 expression in proliferating PASMC. It has been demonstrated that TRP-encoded proteins may be responsible for CCE (4, 5, 37, 44, 45) . Human PASMC from nonpulmonary hypertension patients expressed hTRP1 but not hTRP3 (Fig. 6A) . The mRNA level of hTRP1 was significantly higher in proliferating cells than in growth-arrested cells (Fig. 6) . The enhanced mRNA expression was selective to hTRP1 because the mRNA level of the hVDCC ␤ 2 -subunit was unaltered in proliferating PASMC (Fig.  6B) . These results are consistent with the electrophysiological and fluorescence microscopy experiments showing that I CRAC and CCE were enhanced in human PASMC during proliferation.
Temporal relationship between hTRP1 expression and PASMC proliferation. Whether the mRNA expression of hTRP1 was temporally related to the cell proliferation was examined by comparing the time courses of the change of hTRP1 mRNA levels and the cell growth rate. The cells were first growth arrested by incubation in smooth muscle basal medium (the basal medium without serum and growth factors) for 24-36 h and then cultured in smooth muscle growth medium (smooth muscle basal muscle supplemented with 5% fetal bovine serum and growth factors) for up to 4 days. As shown in Fig. 7 , the cell number in culture dishes (A) and the mRNA level of hTRP1 (B) were both increased after incubating the cells in media containing serum (5% fetal bovine serum) and growth factors (smooth muscle growth medium). However, the time courses are quite different (Fig. 7C) : the mRNA expression of hTRP1 was significantly increased after 6 h of incubation (by 10.1 Ϯ 3.4%, P Ͻ 0.05) in the smooth muscle growth medium (5% fetal bovine serum and growth factors), whereas the cell growth was not significantly increased until 24 h (by 15.4 Ϯ 2.4%, P Ͻ 0.001) (Fig. 7C) . The calculated times for the 50% increase in the hTRP1 mRNA expression and the cell growth are 18.36 and 46.56 h, respectively (Fig. 7C) . These results suggest that enhancement of hTRP1 mRNA expression precedes the onset of cell proliferation in the presence of fetal bovine serum and growth factors. The precise temporal relationship between hTRP1 expression and actual proliferating process (e.g., different cell cycle phases) needs further study.
Elevated resting [Ca 2ϩ ] cyt and [Ca 2ϩ ] SR in growtharrested PASMC from patients with PPH. Patients with SPH (n ϭ 18) and PPH (n ϭ 7), from whom PASMC were isolated, had similar mean pulmonary Temporal relationship between PASMC proliferation and hTRP1 mRNA expression. A: summarized data (means Ϯ SE) showing cell numbers before (day 0) and after incubating the cells in SMGM (with 5% fetal bovine serum and growth factors) or SMBM (without serum and growth factors) for 1-4 days. ***P Ͻ 0.001 vs. day 0. B: PCR amplified products (a) are displayed in agarose gels for hTRP1 (372 bp) and ␤-actin (661 bp) in human PASMC before (0 h) and after incubation in SMGM for 6-60 h. "M", 100 bp DNA ladder. Summarized data (b) that are normalized to the amount of ␤-actin are expressed as means Ϯ SE (PCR experiments were repeated 4 times independently), *P Ͻ 0.05; ***P Ͻ 0.001 vs. growth-arrested cells (0 h). C: relative changes (means Ϯ SE) in cell numbers (F) and hTRP1 mRNA levels (E) in human PASMC cultured with SMBM (day 0) and SMGM (day 0. . The vertical broken lines indicate the time required for a 50% increase in cell growth or hTRP1 mRNA expression. The time-course curve for the increase in hTRP1 expression is significantly different from the curve for the cell growth (P Ͻ 0.001, by Student-Newman-Keuls test).
arterial pressure (48 Ϯ 4 vs. 53 Ϯ 4 mmHg, P ϭ 0.30) and total vascular resistance (13.6 Ϯ 3 vs. 11.2 Ϯ 1.7 mmHg ⅐ l Ϫ1 ⅐ min Ϫ1 , P ϭ 0.48) (41) . However, the resting [Ca 2ϩ ] cyt in quiescent (growth arrested) PASMC (n ϭ 16) from PPH patients was significantly higher than in cells (n ϭ 19) from SPH patients (Fig. 8, A and C) .
In the presence of extracellular Ca 2ϩ , the CPA-induced peak increase in [Ca 2ϩ ] cyt was significantly greater in PPH PASMC (600 Ϯ 70 nM) than in SPH PASMC (350 Ϯ 25 nM, P Ͻ 0.01) (Fig. 8, B, top, and C,  right) receptor-operated channels (36) ; and 3) SOCs (4, 27, 36) . Membrane potential regulates [Ca 2ϩ ] cyt by governing Ca 2ϩ influx via VDCC (24, 42) . The agonist-induced Ca 2ϩ influx is mainly caused by the receptor-mediated activation of receptor-operated channels and store depletion-mediated opening of SOCs (4, 27, 36) . It is likely that depolarization-activated VDCC, agonist-activated receptor-operated channels, and store depletion-activated CCE all contribute to the sustained Ca 2ϩ influx in PASMC during proliferation. Inhibition of CCE by the SOC blocker Ni 2ϩ significantly attenuated human PASMC growth, suggesting that CCE through SOCs is a critical mechanism involved in maintaining sustained Ca 2ϩ influx and refilling Ca 2ϩ into the SR, which are both necessary for PASMC growth. Molecular identification of CCE. Electrophysiological studies on the store depletion-activated I CRAC suggest that SOCs are complex and heterogeneous in molecular composition and in their cellular regulation (4) . There are at least seven members (TRP1-TRP7) in the mouse TRP gene family, of which at least four (TRP1, TRP3, TRP4, and TRP6) have been identified in human tissues (4, 26, 44, 45) . Expression of TRP genes results in the formation of the Ca 2ϩ -permeable cation channels that are activated by Ca 2ϩ store depletion, suggesting that SOCs may be composed of subunits encoded in TRP genes (3-5, 25, 37, 44, 45) . SOCs are hypothesized to be heterotetramers and/or homotetramers made of different TRPs (3, 4, 27) . In mammalian tissues, it has been recently demonstrated that TRP1, TRP2, TRP4, and TRP5 may encode the endogenous SOCs that are activated by store depletion, whereas TRP3, TRP6, and TRP7 may encode the channels that are activated by inositol 1,4,5-trisphosphate (3, 4, 21, 26) and store depletion.
Patch-clamp studies on the store depletion-activated I CRAC indicate that there are multiple SOCs based on the single-channel conductance (0.2-110 pS) (14, 17, 18, 20, 27) . In human PASMC, only the hTRP1 transcript (but not hTRP3 transcript) was identified using RT-PCR, suggesting that hTRP1 is a critical TRP gene that encodes SOCs in human PASMC. In proliferating PASMC, we observed a 5.34-pS channel that was activated by CPA-induced depletion of the SR Ca 2ϩ . These observations suggest that the 5.34-pS channel may be an important SOC that participates in regulating human PASMC growth.
Role of Ca 2ϩ in PASMC Proliferation. Cytosolic Ca 2ϩ stimulates cell proliferation (22, 23, 28, 32) , whereas [Ca 2ϩ ] SR may regulate cell proliferation by modulating the amplitude and frequency of Ca 2ϩ signals in the cytosol and nucleus (6, 8, 19, 33) . Maintaining a sufficient level of Ca 2ϩ in the SR is also critical for cell growth; indeed, depletion of the SR Ca 2ϩ stores induces growth arrest (15, 33) . In the cell cycle, there are four Ca 2ϩ -sensitive steps: transitions 1) from the G 0 (resting state) to the G 1 phase (the beginning of DNA synthesis); 2) from the G 1 to the S phase (an interphase during which replication of the nuclear DNA occurs); 3) from the G 2 to the M phase (mitosis); and 4) through the M phase (22 ] may promote cell growth by 1) activating cytosolic signal transduction proteins (e.g., CREB and mitogen-activated protein kinase) and transcription factors (e.g., c-Fos and c-Jun), 2) moving quiescent cells into the cell cycle and propelling the proliferating cells through mitosis, and 3) enhancing protein and lipid processing in the SR. The intracellular Ca 2ϩ serves as a shared signal transduction element that leads to pulmonary vasoconstriction and vascular medial hypertrophy, two major contributors for the elevated pulmonary vascular resistance (PVR) and arterial pressure (PAP) in patients with PPH. ] SR due to enhanced CCE may also play a role in the development of pulmonary vascular smooth muscle proliferation in patients with PPH (Fig. 9) .
We previously reported that the activity of voltagegated K ϩ channels is significantly decreased in PASMC from PPH patients compared with PASMC from SPH patients (41, 43) . The resultant membrane depolarization increases [Ca 2ϩ ] cyt by opening VDCC and may play an important role in initiating pulmonary vasoconstriction in PPH patients (41, 43 ] cyt and for refilling Ca 2ϩ into the SR, may play an important role in mediating PASMC growth and stimulating pulmonary vascular medial hypertrophy in patients with PPH (Fig. 9) .
